UNIT 14.29 Target‐Induced Natural Killer Cell Loss as a Measure of NK Cell Responses. (April 2013)

• Record Type: Journal Article
• Authors: Warren, Hilary
• Is Part Of: Current protocols in immunology. Volume 101(2013)
• Page Start: 14.29.1
• Page End: 14.29.21
• Publication Date: 2013-04
• Subjects: human NK cells -- cytotoxicity -- ADCC -- Rituximab -- NK cell alloreactivity; Immunology -- Laboratory manuals; Medical protocols; Immunologic Techniques; Medical protocols; Immunology; Laboratory manuals; Reference works; 571.96028
• DOI: 10.1002/0471142735.im1429s101
• Languages: English
• ISSNs: 1934-3671

Abstract

Abstract: Natural killer (NK) cells are an important effector cell of innate immunity. Their interaction with susceptible target cells triggers NK cell cytotoxicity and the release of cytokines. Immunofluorescence flow cytometry–based assays are now the preferred methods for measuring NK cell responses. For these assays, assessment is made on NK cells (CD3 – CD56 + CD16 + ) within the viable lymphocyte gate, defined by the parameters of size (FSC) and granularity (SSC). Accordingly, NK cells that have not dissociated from target cells at the time of measurement, or that have undergone target cell–induced apoptosis, are excluded from the viable lymphocyte gate and therefore from analysis. This unit describes a protocol for assessing NK cell function in response to various target cells (natural killing, antibody‐dependent cell cytotoxicity, and NK cell alloreactivity) based on the loss of NK cells from the lymphocyte gate. This target‐induced NK loss (TINKL) should provide a sensitive measure of NK cell responses in a clinical laboratory setting. Curr. Protoc. Immunol. 101:14.29.1‐14.29.21. © 2013 by John Wiley & Sons, Inc.